Actively Recruiting
Study of Sodium Thiosulfate Added to Kidney Preservation Solution for Improving Outcomes in Deceased Donor Kidney Transplantation
Led by Alp Sener · Updated on 2026-04-13
120
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
End-stage renal disease ESRD is a serious condition requiring dialysis or kidney transplantation. Due to the shortage of living donors, kidneys from deceased donors, including neurologically deceased donors NDD and donation after cardiac death donors DCD, are increasingly used. However, these kidneys face higher risks of injury and delayed function due to lack of blood supply and cold preservation effects. Researchers are studying the addition of sodium thiosulfate STS, a hydrogen sulfide donor, to kidney preservation solutions to improve kidney viability and transplant outcomes.
CONDITIONS
Brief Title
Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation
Research Team
C
Cadence Baker
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here